98 related articles for article (PubMed ID: 2273703)
1. [The changes of population and distribution of S-phase cells in precancerous lesions of rat bladder revealed by the method of bromodeoxyuridine labeling].
Hashimoto H; Sasaki M; Fujisawa M; Kaneko S; Tokunaka S; Yachiku S
Nihon Hinyokika Gakkai Zasshi; 1990 Oct; 81(10):1518-24. PubMed ID: 2273703
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Vinh PQ; Sugie S; Tanaka T; Hara A; Yamada Y; Katayama M; Deguchi T; Mori H
Jpn J Cancer Res; 2002 Jan; 93(1):42-9. PubMed ID: 11802807
[TBL] [Abstract][Full Text] [Related]
3. Assessment of bromodeoxyuridine-labeled S-phase cells in experimentally induced precancerous lesions in the rat's tongue.
Yamamoto Y; Itoh T; Takahashi H
Eur Arch Otorhinolaryngol; 1994; 251(3):160-4. PubMed ID: 8080635
[TBL] [Abstract][Full Text] [Related]
4. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N
Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745
[TBL] [Abstract][Full Text] [Related]
5. Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
Ito N; Fukushima S; Shirai T; Nakanishi K
Environ Health Perspect; 1983 Apr; 50():61-9. PubMed ID: 6873032
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
[TBL] [Abstract][Full Text] [Related]
7. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Sugie S; Vinh PQ; Rahman KM; Ushida J; Kohno H; Suzuki R; Hara A; Quang le B; Tanaka T; Mori H
Int J Cancer; 2005 Nov; 117(4):524-30. PubMed ID: 15929075
[TBL] [Abstract][Full Text] [Related]
9. Enhancing effect of partial cystectomy on rat urinary bladder carcinogenesis.
Tsujihashi H; Nakanishi A; Matsuda H; Uejima S; Kurita T
J Urol; 1991 Jan; 145(1):168-70. PubMed ID: 1984084
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice.
Yang M; Tanaka T; Hirose Y; Deguchi T; Mori H; Kawada Y
Int J Cancer; 1997 Nov; 73(5):719-24. PubMed ID: 9398052
[TBL] [Abstract][Full Text] [Related]
11. Promoting effects of unilateral ureteric ligation on two-stage urinary bladder carcinogenesis in rats.
Miyata Y; Fukushima S; Imaida K; Ito N
Cancer Lett; 1984 Jul; 23(3):265-72. PubMed ID: 6744250
[TBL] [Abstract][Full Text] [Related]
12. The kinetics of cellular proliferation in rat urinary bladder treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T
J Urol; 1990 Dec; 144(6):1493-6. PubMed ID: 2231954
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
Wakui S; Mutou T; Takahashi H; Ikegami M; Wanibuchi H; Fukushima S
J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of cytokeratin 14 and 18 in bladder cancer tumorigenesis.
Li YP; Jia XP; Jiang YQ; Wang W; Wang YL; Wang XL; Guo YX
Exp Biol Med (Maywood); 2018 Feb; 243(4):344-349. PubMed ID: 29350066
[TBL] [Abstract][Full Text] [Related]
16. Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound.
Li W; Wanibuchi H; Salim EI; Yamamoto S; Yoshida K; Endo G; Fukushima S
Cancer Lett; 1998 Dec; 134(1):29-36. PubMed ID: 10381127
[TBL] [Abstract][Full Text] [Related]
17. DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium.
Dahm HH; von der Haar C; Rübben H
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1253-60. PubMed ID: 27033373
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N
Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979
[TBL] [Abstract][Full Text] [Related]
20. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
Miyata Y; Fukushima S; Hirose M; Masui T; Ito N
Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
